Skip To Content
 

Search:

 

Diagnostic Imaging Pathways - Staging Of Non-Small Cell Lung Cancer
PathwaysHome
Flow Chart
Image gallery
Teaching Points
References
PDF Version
Consumer Information

References

  1. Patz EF Jr. Imaging bronchogenic carcinoma. Chest 2000;117:90S-5S.
  2. Park BJ, Louie O, Altorki N, et al. Staging and the surgical management of lung cancer. Radiologic clinics of North America 2000;38(3):545-61.
  3. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991; 178(3): 705-13. (Level II/III evidence)
  4. Marom E, McAdams HP, Erasmus JJ, et al. Staging non-small cell lung cancer with whole-body PET. Radiology 1999; 212: 803-9. (Level II evidence). Click here to view reference
  5. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182(2): 319-23. (Level II evidence). Click here to view reference
  6. Gdeedo A, van Schil P, Courthouts B, et al. Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. Eur Resp J 1997;10:1547-51. (Level II/III evidence)
  7. Oliver TW, Bernardino ME, Miller JI, et al. Isolated adrenal masses in non small-cell bronchogenic carcinoma. Radiology 1984;153:217-18. (Level II/III evidence)
  8. Colice GL, Birkmeyer JD, Black WC, et al. Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases. Chest 1995;108:1264-71. (Level III evidence)
  9. Yokoi K, Kamiya N, Matsuguma H, et al. Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI. Chest 1999;115:714-9. (Level III evidence)
  10. Salbeck R, Grau HC, Artmann H. Cerebral tumour staging in patients with bronchial carcinoma by computed tomography. Cancer 1990; 66(9):2007-11. (Level III evidence)
  11. Heelan RT, Demas BE, Caravelli JF, et al. Superior sulcus tumors: CT and MR imaging. Radiology 1989;170(3):637-41. (Level III evidence )
  12. Padovani B, Mouroux J, Seksik L, et al. Chest wall invasion by bronchogenic carcinoma: evaluation with MR imaging. Radiology 1993;187:33-8. (Level II/III evidence)
  13. Michel F, Soler M, Imhof E, et al. Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning. Thorax 1991;46(7):469-73. (Level II evidence). Click here to view reference
  14. Dwamena BA, Sonnad SS, Angobaldo JO, et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s - Meta-analytic comparison of PET and CT. Radiology 1999;213:530-6. (Level II/III evidence)
  15. Gupta NC, Graeber GM, Rogers JS II, et al. Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer. Ann Surg 1999;229:286-91. (Level II/III evidence)
  16. Vansteenkiste JF, Mortelmans KA. FDG-PET in the locoregional staging of non-small cell lung cancer: a comprehensive review of the Leuven Lung Cancer Group experience. Clin Pos Imaging 1999;2:223-31.
  17. Steinert HC, Hauser M, Allemann F, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997;202:441-6. (Level III evidence)
  18. Gambhir SS, Hoh CK, Phelps ME, et al. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non small-cell lung carcinoma. J Nucl Med 1996;37:1428-36.
  19. Shepherd JE, Phelps ME, Czernin J, et al. Cost-effectiveness analysis for the role of FDG-PET in lung carcinoma. J Nucl Med 1999;40:56P.
  20. Young WF Jr. Management approaches to adrenal incidentalomas. Endocrinol Metab Clin North Am 2000;29(1):159-85.
  21. Herrera MF, Grant CS, van Heerden JA, et al. Incidentally discovered adrenal tumours: an institutional perspective. Surgery 1991;110(6):1014-21.
  22. Barry MK, van Heerden JA, Farley DR, et al. Can adrenal incidentalomas be safely observed? World J Surg 1998;22:599-604. (Level III evidence)
  23. McNicholas MM, Lee MJ, Mayo-Smith WW, et al. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. AJR 1995;165:1453-9. (Level III evidence)
  24. Pender SM, Boland GW, Lee MJ, et al. The incidental nonhyperfunctioning adrenal mass: an imaging algorithm for characterisation. Clinical Radiology 1998;53:796-804.
  25. Lee MJ, Hahn PF, Papanicolaou N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991;179:415-8. (Level III evidence)
  26. Boland GWL, Lee MJ, Gazelle GS, et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR 1998;171:201-4. (Level II evidence). Click here to view reference
  27. Caoilli EM, Korobkin M, Francis IR, et al. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 2002;222:629-33. (Level II/III evidence)
  28. Toloza EM, Harpole L, Detterbeck F, McCrory DC. Invasive Staging of Non-small Cell Lung Cancer: A review of the current evidence. Chest 2003;123:157S-166S. (Level II evidence) Click here to view reference
  29. Kramer H, van Putten JW, van Dullemen HM, et al. Oesophageal endoscopic ultrasound with fine needle aspiration improves and simplifies the staging of lung cancer. Thorax 2004;59:596-601. (Level II evidence) Click here to view reference
  30. Vilmann P, Krasnik M, Larsen SS, Jacobsen GK, Clementsen P. Transesophageal Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA) and Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) Biopsy: a Combined Approach in the Evaluation of Mediastinal Lesions. Endoscopy 2005;37:833-39. (Level II/III evidence)
  31. Eloubeidi MA, Cerfolio RJ, Chen VK, Desmond R, Syed S, Ojha B. Endoscopic Ultrasound-Guided Fine Needle Aspiration of Mediastinal Lymph Node in Patients With Suspected Lung Cancer After Positron Emission Tomography and Computed Tomography Scans. Ann Thorac Surg 2005;79:263-8 (Level II/III evidence)
  32. Annema JT, Versteegh MI, Veselic M, et al. Endoscopic Ultrasound Added to Mediastinoscopy for Preoperative Staging of Patients With Lung Cancer. JAMA 2005;294:931-36. (Level II evidence) Click here to view reference
  33. Green FL, Page DL, Fleming ID, et al. (eds). AJCC Cancer Staging Manual, Sixth Edition. Springer-Verlag: New York 2002.
  34. Detterbeck FC, Jones DR, Parker LA. Intrathoracic staging. In: Detterbeck FC, Rivera MP, Socinski MA, Rosenman JG, eds. Diagnosis and treatment of lung cancer: an evidence-based guide for the practicing clinician, 5, 2001. pp73-93. Philadelphia: W.B. Saunders Company. (Level II evidence)
  35. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer: A review of the current evidence. Chest 2003; 123:137S-146S. (Level II evidence) Click here to view reference
  36. Birim O, Kappetein AP, Stijnen T et al. Meta-analysis of positron emission tomography and computed tomography imaging in detecting mediatstinal lymph node metastases in non-small cell lung cancer. Ann Thorac Surg 2005; 79:375-382. (Level II evidence) Click here to view reference
  37. National Collaborating Centre for Acute Car. Diagnosis and treatment of lung cancer. National Collaborating Centre for Acute Care, London, February 2005. [cited November 3 2006] Available from www.nice.org.uk Click here to view reference
  38. De Leyn P, Lardinois D, Van Schil P et al. Preoperative lymph node staging for non-small cell lung cancer. European Society of Thoracic Surgeons guidelines 2006. [cited November 3 2006] Available from www.ests.org (Review article) Click here to view reference
  39. Verhagen AT, Bootsma GP, Tjan-Heijnen VC et al. FDG-PET in staging lung cancer: How does it change the algorithm? Lung Cancer 2004; 44:175-181. (Level II evidence) Click here to view reference
  40. De Langen AJ, Raijmakers P, Riphagen I, Paul MA, Hoekstra OS. The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis. Eur J Cardiothorac Surg 2006; 29:26-29. (Level II evidence) Click here to view reference
  41. Yap CS, Schiepers C, Fishbein MC, Phelps ME, Czernin J. FDG-PET imaging in lung cancer: how sensitive is it for bronchioalveolar carcinoma? Eur J Nucl Med Mol Imaging 2002; 29:1166-1173. (Level II evidence)
  42. Reed Ce, Harpole DH, Posther KE et al. Results of the American College of Surgeons Oncology Group Z0050 trial: The utility of positron emission tomography in staging potentially operable non-small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery 2003; 126:1943-51. (Level II evidence) Click here to view reference
  43. 43. Lardinois D, Weder W, Hany TF et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348:2500-2507. (Level II evidence) Click here to view reference
  44. Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg 2004; 78:1017-1023. (Level II evidence) Click here to view reference
  45. Pozo-Rodriguez F, Martin de Nicolas JL, Sanchez-Nistal MA et al. Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially respectable non-small-cell cancer. J Clin Oncol 2005; 23:8348-8356. (Level II evidence) Click here to view reference
  46. Marom EM, McAdams HP, Erasmus JJ et al. Staging non-small cell lung cancer with whole-body PET. Radiology 1999; 212:8-3-809. (Level III evidence)
  47. Cheran SK, Hendon JE, Patz EF Jr. Comparison of whole-body FDG-PET to bone scan or detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer 2004; 44:317-25. (Level III evidence)
  48. Gayed I, Vu T, Johnson M, Macapinlac H, Podoloff D. Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer. Mol Imaging Biol 2003; 5:26-31. (Level III evidence)
  49. Hsia TC, Shen YY, Yen RF, Kao CH, Changlai SP. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. Neoplasma 2002; 49:267-71. (Level III evidence)
  50. Annema JT, Hoekstra OS, Smit EF, Veselic M, Versteegh MI, Rabe KF. Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA. Lung Cancer 2004; 22:53-60. (Level II evidence) Click here to view reference
  51. Fritscher-Ravens A, Bohuslavizki KH, Brandt L et al. Mediastinal lymph node involvement in potentially resectable lung cancer: comparison of CT, positron emission tomography and endoscopic ultrasonography with and without fine-needle aspiration. Chest 2003; 123:442-451. (Level II evidence) Click here to view reference
  52. Caddy G, Conron M, Wright G, Desmond P, Hart d, Chen RY. The accuracy of EUS-FNA in assessing mediastinal lymphadenopathy and staging patients with NSCLC. Eur Respir J 2005; 25:410-415. (Level II evidence) Click here to view reference
  53. Yasufuku K, Chiyo M, Koh E et al. Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer. Lung Cancer 2005; 50:347-354. (Level II evidence) Click here to view reference
  54. Larsen SS, Viman P, Krasnik M et al. Endoscopic ultrasound guided biopsy versus mediastinoscopy for analysis of paratracheal and subcarinal lymph nodes in lung cancer staging. Lung Cancer 2005; 48:85-92. (Level II evidence) Click here to view reference
  55. Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, Detterbeck F; American College of Chest Physicians. Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 Suppl):178S-201S. (Guidelines)
  56. Lim E, Baldwin D, Beckles M, Duffy J, Entwisle J, Faivre-Finn C, Kerr K, Macfie A, McGuigan J, Padley S, Popat S, Screaton N, Snee M, Waller D, Warburton C, Win T; British Thoracic Society; Society for Cardiothoracic Surgery in Great Britain and Ireland. Guidelines on the radical management of patients with lung cancer. Thorax. 2010;65 Suppl 3:iii1-27. (Guidelines)
  57. Higashino T, Ohno Y, Takenaka D, Watanabe H, Nogami M, Ohbayashi C, Yoshimura M, Satouchi M, Nishimura Y, Fujii M, Sugimura K. Thin-section multiplanar reformats from multidetector-row CT data: utility for assessment of regional tumor extent in non-small cell lung cancer. Eur J Radiol. 2005;56(1):48-55.
  58. Micames CG, McCrory DC, Pavey DA, Jowell PS, Gress FG. Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Non-small Cell Lung Cancer Staging : A Systematic Review and Metaanalysis. Chest 2007;131;539-548. (Level I evidence).
  59. Annema JT, van Meerbeeck JP, Rintoul RC, Dooms C, Deschepper E, Dekkers OM, et al. Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA. 2010 Nov 24;304(20):2245-52.

Further Reading

  1. Goldsmith SJ, Kostakoglu L. Nuclear medicine imaging of lung cancer. Radiologic Clinics of North America 2000;38(2):511-24.

File Formats

Some documents for download on this website are in a Portable Document Format (PDF). To read these files you might need to download Adobe® Acrobat Reader.

Get Adobe Reader

Legal Matters